Novavax, Inc. (NVAX): Price and Financial Metrics
NVAX Price/Volume Stats
| Current price | $8.70 | 52-week high | $23.86 |
| Prev. close | $8.68 | 52-week low | $3.53 |
| Day low | $8.37 | Volume | 6,088,800 |
| Day high | $8.89 | Avg. volume | 9,218,753 |
| 50-day MA | $9.21 | Dividend yield | N/A |
| 200-day MA | $10.51 | Market Cap | 1.39B |
NVAX Stock Price Chart Interactive Chart >
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
NVAX Price Returns
| 1-mo | 8.21% |
| 3-mo | -32.61% |
| 6-mo | -37.95% |
| 1-year | 71.94% |
| 3-year | -95.25% |
| 5-year | 117.50% |
| YTD | 81.25% |
| 2023 | -53.31% |
| 2022 | -92.81% |
| 2021 | 28.30% |
| 2020 | 2,701.76% |
| 2019 | -89.18% |
Continue Researching NVAX
Want to see what other sources are saying about Novavax Inc's financials and stock price? Try the links below:Novavax Inc (NVAX) Stock Price | Nasdaq
Novavax Inc (NVAX) Stock Quote, History and News - Yahoo Finance
Novavax Inc (NVAX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...